Skip to main content
Marc Barry, MD
Subspecialty Director: Genitourinary Pathology
Subspecialties: Genitourinary and medical renal pathology
Associate Professor, University of Utah School of Medicine
Specialties
Renal pathology
Genitourinary
Education
Medical Degree—University College Dublin
Residency—Anatomic Pathology, Brigham and Women’s Hospital
Research Fellowship—Massachusetts Institute of Technology
Fellowship—Medical Renal Pathology, Brigham and Women’s Hospital
Fellowship—Urologic Pathology, Brigham and Women’s Hospital
Certifications/Affiliations
American Board of Pathology
United States and Canadian Academy of Pathology
American Society for Clinical Pathology
College of American Pathologists
Research Interests
Clinicopathologic questions in medical renal and urologic pathology
Epidemiologic and translational aspects of urologic neoplasia
Awards
Registrar’s Prize for Research from the Royal Academy of Medicine in Ireland, 2000
Research Scholarship Award from the College of American Pathology Foundation, 2004
Prize from the journal “Urology” for the best paper in 2007 by a resident or fellow, 2008
Formally recognized for “Excellence in Urologic Resident Education” by the Division of Urology, University of New Mexico School of Medicine, 2014
Recent Publications
Berggren KL, et al. MAPKAPK2 (MK2) inhibition mediates radiation-induced inflammatory cytokine production and tumor growth in head and neck squamous cell carcinoma . Oncogene . 2019 Nov;38(48):7329–41.
Nash SH, et al. Cancer survival among Alaska Native people . Cancer . 2018 Jun 15;124(12):2570–7.
Hill DA, et al. Breast cancer survival, survival disparities, and guideline-based treatment . Breast Cancer Res Treat . 2018 Jul;170(2):40–14.
Hill DA, et al. Estrogen receptor quantitative measures and breast cancer survival . Breast Cancer Res Treat . 2017 Dec;166(3): 855–64.
Teixeira AA, et al. Going viral? Linking the etiology of human prostate cancer to the PCA3 long noncoding RNA and oncogenic viruses . EMBO Mol Med . 2017 Oct 9(10):1327–30.
Ferrara F, et al. Targeted molecular-genetic imaging and ligand-directed therapy in aggressive variant prostate cancer . Proc Natl Acad Sci U S A . 2016 Nov 8;113(45):12786–91.
Dobroff AS, et al. Towards a transcriptome-based theranostic platform for unfavorable breast cancer phenotypes . Proc Natl Acad Sci U S A . 2016 Nov 8;113(45):12780–5.
Vigil D, et al. BK nephropathy in the native kidneys of patients with organ transplants: clinical spectrum of BK infection . World J Transplant , 2016 Sept 24;6(3):472–504.
Reynolds S, et al. A case of primary mammary analog secretory carcinoma (MASC) of the thyroid masquerading as papillary thyroid carcinoma: potentially more than a one off . Head Neck Pathol . 2016 Sept;10(3):405–13.
Hoffman RM, et al. Trends in United States prostate cancer incidence rates by age and stage, 1995–2012 . Cancer Epidemiol Biomarkers Prev . 2016 Feb;25(2):259–63.